TP53 and lung cancer: Genetically Engineered Mouse (GEM) models utilizing known mutations identified in lung cancer patients (e.g. KRAS, p53, ALK) cause cancers to form orthotopically, however the long latency of cancer initiation and sporadic metastases20–23 reduce experimental feasibility.